✦ LIBER ✦
390 TH-302, a tumor selective hypoxia activated prodrug, complements and enhances chemotherapy treatment with gemcitabine, docetaxel, pemetrexed, and doxorubicin
✍ Scribed by C.P. Hart; M. Borad; S.P. Chawla; J.R. Infante; K.N. Ganjoo; V.K. Langmuir; S. Kroll; J.G. Curd
- Book ID
- 119603073
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 45 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.